Sage Therapeutics Overview
Sage Therapeutics Target Price
Analysts' 12-month price predictions for SAGE.
Share Price
$11.7
Average Target Price
$21.43
83.2% upside
83.2% upside7 analysts in the last 4 months
High: $28 | Low: $17
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-04-25 | Truist FinancialJoon Lee | $18 | 53.8% upside |  |
| 2024-04-18 | ScotiabankGeorge Farmer | $19 | 62.4% upside | |
| 2024-04-17 | OppenheimerJay Olson | $17 | 45.3% upside | |
| 2024-04-17 | RBC CapitalBrian Abrahams | $26 | 122.2% upside | |
| 2024-04-17 | Mizuho SecuritiesVamil Divan | $20 | 70.9% upside | |
| 2024-04-17 | Goldman SachsSalveen Richter | $28 | 139.3% upside | |
| 2024-04-17 | Truist FinancialJoon Lee | $22 | 88% upside | |
| 2022-12-06 | J.P. Morgan | $60 | 412.8% upside | |
| 2022-11-11 | Guggenheim | $48 | 310.3% upside | |
| 2022-06-20 | Piper SandlerYasmeen Rahimi | $100 | 754.7% upside | |
| 2022-05-04 | RBC Capital | $35 | 199.1% upside | |
| 2022-02-25 | BMO CapitalGary Nachman | $48 | 310.3% upside | |
| 2022-02-24 | Stifel NicolausPaul Matteis | $58 | 395.7% upside | |
| 2022-02-24 | RBC CapitalBrian Abrahams | $37 | 216.2% upside | |
| 2022-02-24 | Leerink PartnersMarc Goodman | $50 | 327.4% upside | |
| 2022-02-17 | OppenheimerJay Olson | $74 | 532.5% upside | |
| 2021-11-02 | GuggenheimYatin Suneja | $55 | 370.1% upside | |
| 2021-10-06 | JefferiesAkash Tewari | $50 | 327.4% upside | |
| 2021-08-03 | WedbushLaura Chico | $80 | 583.8% upside | |
| 2021-06-16 | CitigroupNeena Bitritto-Garg | $68 | 481.2% upside | |
| 2021-06-15 | Cowen & Co.Ritu Baral | $105 | 797.4% upside | |